| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/0197-2456(93)90228-6 |
| P698 | PubMed publication ID | 8365195 |
| P50 | author | Garnet L Anderson | Q37387870 |
| Gil Omenn | Q5560581 | ||
| P2093 | author name string | M Cherniack | |
| S Barnhart | |||
| J E Grizzle | |||
| J Balmes | |||
| S Hammar | |||
| G E Goodman | |||
| L Rosenstock | |||
| M D Thornquist | |||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | statistics | Q12483 |
| P304 | page(s) | 308-324 | |
| P577 | publication date | 1993-08-01 | |
| P1433 | published in | Contemporary Clinical Trials | Q5164971 |
| P1476 | title | Statistical design and monitoring of the Carotene and Retinol Efficacy Trial (CARET) | |
| P478 | volume | 14 |
| Q37107033 | Anti-HE4 antibodies in infertile women and women with ovarian cancer |
| Q33602930 | Antioxidant potentials of vitamin A and carotenoids and their relevance to heart disease |
| Q24242191 | Antioxidant supplements for preventing gastrointestinal cancers |
| Q24245704 | Antioxidant supplements for preventing gastrointestinal cancers |
| Q24201127 | Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases |
| Q24242944 | Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases |
| Q33574039 | Assessing lead time of selected ovarian cancer biomarkers: a nested case-control study |
| Q50320608 | Body mass index and lung cancer risk: a pooled analysis based on nested case-control studies from four cohort studies |
| Q52664872 | Body mass index and prostate cancer risk in the Carotene and Retinol Efficacy Trial. |
| Q46598987 | Changes in cholesterol and triglyceride concentrations in the Vanguard population of the Carotene and Retinol Efficacy Trial (CARET). |
| Q34590376 | Chromosome 15q24-25.1 variants, diet, and lung cancer susceptibility in cigarette smokers |
| Q33910108 | Designing cancer prevention trials: a stochastic model approach |
| Q37322524 | Dietary supplement use and prostate cancer risk in the Carotene and Retinol Efficacy Trial |
| Q24198265 | Drugs for preventing lung cancer in healthy people |
| Q24248776 | Drugs for preventing lung cancer in healthy people |
| Q90043741 | Drugs for preventing lung cancer in healthy people |
| Q40784591 | Effects of incentive items on participation in a randomized chemoprevention trial |
| Q34314018 | Genome-wide association study identifies multiple susceptibility loci for pancreatic cancer |
| Q36773349 | Hierarchical modeling identifies novel lung cancer susceptibility variants in inflammation pathways among 10,140 cases and 11,012 controls |
| Q33711781 | Interlaboratory reliability of microimmunofluorescence test for measurement of Chlamydia pneumoniae-specific immunoglobulin A and G antibody titers |
| Q40867722 | Mailing strategies and costs of recruiting heavy smokers in CARET, a large chemoprevention trial |
| Q44297730 | Stopping the active intervention: CARET. |
| Q35968226 | The Beta-Carotene and Retinol Efficacy Trial: incidence of lung cancer and cardiovascular disease mortality during 6-year follow-up after stopping beta-carotene and retinol supplements |
Search more.